Global Peptide Cancer Vaccine Market Insights, Forecast to 2025

Publisher Name :
Date: 08-Mar-2019
No. of pages: 117
Inquire Before Buying

Cancer peptide vaccination, as an immunotherapeutic approach against solid tumors, is currently employed in several clinical research protocols. The underlying mechanism of peptide-based vaccines involves the generation of a T-cell immune response against tumor or enhancement of an endogenous antitumor immunity pre-existing in the host.

Cancer peptide vaccination, as an immunotherapeutic approach against solid tumors, is currently employed in several clinical research protocols. The underlying mechanism of peptide-based vaccines involves the generation of a T-cell immune response against tumor or enhancement of an endogenous antitumor immunity pre-existing in the host.

With the ever increasing new cancer cases across the globe and the conventional treatment methods unable to cope up with the challenges posed by the tumor and their immune response evading techniques, cancer immunotherapy brings a ray of hope. Cancer immunotherapy allows the host's immune cells to get sensitized with the tumor-associated antigens which in turn elicits B cell and T cell mediated immune response to target and eliminate tumor cells. This is the underlying principle of cancer immunotherapy.

Peptide Cancer Vaccine can be used for Breast Cancer, Lung Cancer, Melanoma, Prostate Cancer and Others cancers. The most proportion research of Peptide Cancer Vaccine is about Melanoma, and the proportion in 2025 is about 40%.

The global Peptide Cancer Vaccine market is valued at 280 million US$ in 2018 and will reach 1120 million US$ by the end of 2025, growing at a CAGR of 22.2% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Peptide Cancer Vaccine market based on company, product type, end user and key regions.

This report studies the global market size of Peptide Cancer Vaccine in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Peptide Cancer Vaccine in these regions.

This research report categorizes the global Peptide Cancer Vaccine market by top players/brands, region, type and end user. This report also studies the global Peptide Cancer Vaccine market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:

- TapImmune

- BrightPath Biotherapeutics

- Ultimovacs

- Sellas

- Boston Biomedical

- Imugene

- VAXON Biotech

- Generex Biotechnology

- ISA Pharmaceuticals

- OncoTherapy Science

- Immatics

Market size by Product

- Type I

- Type II

Market size by End User

- Breast Cancer

- Lung Cancer

- Melanoma

- Prostate Cancer

- Others

Market size by Region

- North America

- - United States

- - Canada

- - Mexico

- Asia-Pacific

- - China

- - India

- - Japan

- - South Korea

- - Australia

- - Indonesia

- - Singapore

- - Malaysia

- - Philippines

- - Thailand

- - Vietnam

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Spain

- - Russia

- Central & South America

- - Brazil

- - Rest of Central & South America

- Middle East & Africa

- - GCC Countries

- - Turkey

- - Egypt

- - South Africa

The study objectives of this report are:

- To study and analyze the global Peptide Cancer Vaccine market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.

- To understand the structure of Peptide Cancer Vaccine market by identifying its various subsegments.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- Focuses on the key global Peptide Cancer Vaccine companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.

- To project the value and sales volume of Peptide Cancer Vaccine submarkets, with respect to key regions.

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Peptide Cancer Vaccine are as follows:

- History Year: 2014-2018

- Base Year: 2018

- Estimated Year: 2019

- Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Doses). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Peptide Cancer Vaccine market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Global Peptide Cancer Vaccine Market Insights, Forecast to 2025

Table of Contents
1 Study Coverage
1.1 Peptide Cancer Vaccine Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Peptide Cancer Vaccine Market Size Growth Rate by Product
1.4.2 Type I
1.4.3 Type II
1.5 Market by End User
1.5.1 Global Peptide Cancer Vaccine Market Size Growth Rate by End User
1.5.2 Breast Cancer
1.5.3 Lung Cancer
1.5.4 Melanoma
1.5.5 Prostate Cancer
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Peptide Cancer Vaccine Market Size
2.1.1 Global Peptide Cancer Vaccine Revenue 2014-2025
2.1.2 Global Peptide Cancer Vaccine Sales 2014-2025
2.2 Peptide Cancer Vaccine Growth Rate by Regions
2.2.1 Global Peptide Cancer Vaccine Sales by Regions
2.2.2 Global Peptide Cancer Vaccine Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Peptide Cancer Vaccine Sales by Manufacturers
3.1.1 Peptide Cancer Vaccine Sales by Manufacturers
3.1.2 Peptide Cancer Vaccine Sales Market Share by Manufacturers
3.1.3 Global Peptide Cancer Vaccine Market Concentration Ratio (CR5 and HHI)
3.2 Peptide Cancer Vaccine Revenue by Manufacturers
3.2.1 Peptide Cancer Vaccine Revenue by Manufacturers (2014-2019)
3.2.2 Peptide Cancer Vaccine Revenue Share by Manufacturers (2014-2019)
3.3 Peptide Cancer Vaccine Price by Manufacturers
3.4 Peptide Cancer Vaccine Manufacturing Base Distribution, Product Types
3.4.1 Peptide Cancer Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Peptide Cancer Vaccine Product Type
3.4.3 Date of International Manufacturers Enter into Peptide Cancer Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Peptide Cancer Vaccine Sales by Product
4.2 Global Peptide Cancer Vaccine Revenue by Product
4.3 Peptide Cancer Vaccine Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Peptide Cancer Vaccine Breakdown Data by End User
6 North America
6.1 North America Peptide Cancer Vaccine by Countries
6.1.1 North America Peptide Cancer Vaccine Sales by Countries
6.1.2 North America Peptide Cancer Vaccine Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Peptide Cancer Vaccine by Product
6.3 North America Peptide Cancer Vaccine by End User
7 Europe
7.1 Europe Peptide Cancer Vaccine by Countries
7.1.1 Europe Peptide Cancer Vaccine Sales by Countries
7.1.2 Europe Peptide Cancer Vaccine Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Peptide Cancer Vaccine by Product
7.3 Europe Peptide Cancer Vaccine by End User
8 Asia Pacific
8.1 Asia Pacific Peptide Cancer Vaccine by Countries
8.1.1 Asia Pacific Peptide Cancer Vaccine Sales by Countries
8.1.2 Asia Pacific Peptide Cancer Vaccine Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Peptide Cancer Vaccine by Product
8.3 Asia Pacific Peptide Cancer Vaccine by End User
9 Central & South America
9.1 Central & South America Peptide Cancer Vaccine by Countries
9.1.1 Central & South America Peptide Cancer Vaccine Sales by Countries
9.1.2 Central & South America Peptide Cancer Vaccine Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Peptide Cancer Vaccine by Product
9.3 Central & South America Peptide Cancer Vaccine by End User
10 Middle East and Africa
10.1 Middle East and Africa Peptide Cancer Vaccine by Countries
10.1.1 Middle East and Africa Peptide Cancer Vaccine Sales by Countries
10.1.2 Middle East and Africa Peptide Cancer Vaccine Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Peptide Cancer Vaccine by Product
10.3 Middle East and Africa Peptide Cancer Vaccine by End User
11 Company Profiles
11.1 TapImmune
11.1.1 TapImmune Company Details
11.1.2 Company Business Overview
11.1.3 TapImmune Peptide Cancer Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.1.4 TapImmune Peptide Cancer Vaccine Products Offered
11.1.5 TapImmune Recent Development
11.2 BrightPath Biotherapeutics
11.2.1 BrightPath Biotherapeutics Company Details
11.2.2 Company Business Overview
11.2.3 BrightPath Biotherapeutics Peptide Cancer Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.2.4 BrightPath Biotherapeutics Peptide Cancer Vaccine Products Offered
11.2.5 BrightPath Biotherapeutics Recent Development
11.3 Ultimovacs
11.3.1 Ultimovacs Company Details
11.3.2 Company Business Overview
11.3.3 Ultimovacs Peptide Cancer Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Ultimovacs Peptide Cancer Vaccine Products Offered
11.3.5 Ultimovacs Recent Development
11.4 Sellas
11.4.1 Sellas Company Details
11.4.2 Company Business Overview
11.4.3 Sellas Peptide Cancer Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Sellas Peptide Cancer Vaccine Products Offered
11.4.5 Sellas Recent Development
11.5 Boston Biomedical
11.5.1 Boston Biomedical Company Details
11.5.2 Company Business Overview
11.5.3 Boston Biomedical Peptide Cancer Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Boston Biomedical Peptide Cancer Vaccine Products Offered
11.5.5 Boston Biomedical Recent Development
11.6 Imugene
11.6.1 Imugene Company Details
11.6.2 Company Business Overview
11.6.3 Imugene Peptide Cancer Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Imugene Peptide Cancer Vaccine Products Offered
11.6.5 Imugene Recent Development
11.7 VAXON Biotech
11.7.1 VAXON Biotech Company Details
11.7.2 Company Business Overview
11.7.3 VAXON Biotech Peptide Cancer Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.7.4 VAXON Biotech Peptide Cancer Vaccine Products Offered
11.7.5 VAXON Biotech Recent Development
11.8 Generex Biotechnology
11.8.1 Generex Biotechnology Company Details
11.8.2 Company Business Overview
11.8.3 Generex Biotechnology Peptide Cancer Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Generex Biotechnology Peptide Cancer Vaccine Products Offered
11.8.5 Generex Biotechnology Recent Development
11.9 ISA Pharmaceuticals
11.9.1 ISA Pharmaceuticals Company Details
11.9.2 Company Business Overview
11.9.3 ISA Pharmaceuticals Peptide Cancer Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.9.4 ISA Pharmaceuticals Peptide Cancer Vaccine Products Offered
11.9.5 ISA Pharmaceuticals Recent Development
11.10 OncoTherapy Science
11.10.1 OncoTherapy Science Company Details
11.10.2 Company Business Overview
11.10.3 OncoTherapy Science Peptide Cancer Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.10.4 OncoTherapy Science Peptide Cancer Vaccine Products Offered
11.10.5 OncoTherapy Science Recent Development
11.11 Immatics
12 Future Forecast
12.1 Peptide Cancer Vaccine Market Forecast by Regions
12.1.1 Global Peptide Cancer Vaccine Sales Forecast by Regions 2019-2025
12.1.2 Global Peptide Cancer Vaccine Revenue Forecast by Regions 2019-2025
12.2 Peptide Cancer Vaccine Market Forecast by Product
12.2.1 Global Peptide Cancer Vaccine Sales Forecast by Product 2019-2025
12.2.2 Global Peptide Cancer Vaccine Revenue Forecast by Product 2019-2025
12.3 Peptide Cancer Vaccine Market Forecast by End User
12.4 North America Peptide Cancer Vaccine Forecast
12.5 Europe Peptide Cancer Vaccine Forecast
12.6 Asia Pacific Peptide Cancer Vaccine Forecast
12.7 Central & South America Peptide Cancer Vaccine Forecast
12.8 Middle East and Africa Peptide Cancer Vaccine Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Peptide Cancer Vaccine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables and Figures
Figure Peptide Cancer Vaccine Product Picture
Table Peptide Cancer Vaccine Market Segments
Table Key Manufacturers Peptide Cancer Vaccine Covered
Table Global Peptide Cancer Vaccine Market Size Growth Rate by Product 2019-2025 (K Doses) & (Million US$)
Figure Global Peptide Cancer Vaccine Sales Market Share by Product 2014-2025
Figure Type I Product Picture
Table Major Manufacturers of Type I
Figure Type II Product Picture
Table Major Manufacturers of Type II
Table Global Peptide Cancer Vaccine Market Size Growth Rate by End User 2019-2025 (K Doses)
Figure Breast Cancer
Figure Lung Cancer
Figure Melanoma
Figure Prostate Cancer
Figure Others
Figure Peptide Cancer Vaccine Report Years Considered
Figure Global Peptide Cancer Vaccine Market Size 2014-2025 (Million US$)
Figure Global Peptide Cancer Vaccine Sales 2014-2025 (K Doses)
Table Global Peptide Cancer Vaccine Market Size by Regions 2014-2019 (K Doses) & (Million US$)
Table Global Peptide Cancer Vaccine Sales by Regions 2014-2019 (K Doses)
Table Global Peptide Cancer Vaccine Sales Market Share by Regions 2014-2019
Figure Global Peptide Cancer Vaccine Sales Market Share by Regions 2014-2019
Figure 2018 Global Peptide Cancer Vaccine Sales Market Share by Regions
Table Global Peptide Cancer Vaccine Revenue by Regions 2014-2019 (Million US$)
Table Global Peptide Cancer Vaccine Revenue Market Share by Regions 2014-2019
Figure Global Peptide Cancer Vaccine Revenue Market Share by Regions 2014-2019
Figure 2018 Global Peptide Cancer Vaccine Revenue Market Share by Regions
Table Global Peptide Cancer Vaccine Sales by Manufacturers (2014-2019) (K Doses)
Table Global Peptide Cancer Vaccine Sales Share by Manufacturers (2014-2019)
Figure Global Peptide Cancer Vaccine Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Peptide Cancer Vaccine Revenue by Manufacturers (2014-2019) (Million USD)
Table Peptide Cancer Vaccine Revenue Share by Manufacturers (2014-2019)
Figure Peptide Cancer Vaccine Value Share by Manufacturers in 2018
Table Key Manufacturers Peptide Cancer Vaccine Price (2014-2019) (USD/Dose)
Table Peptide Cancer Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Peptide Cancer Vaccine Product Type
Table Date of International Manufacturers Enter into Peptide Cancer Vaccine Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Peptide Cancer Vaccine Sales by Product (2014-2019) (K Doses)
Table Global Peptide Cancer Vaccine Sales Share by Product (2014-2019)
Figure Global Peptide Cancer Vaccine Sales Market Share by Product (2014-2019)
Figure Global Peptide Cancer Vaccine Sales Market Share by Product in 2018
Table Global Peptide Cancer Vaccine Revenue by Product (2014-2019) (Million US$)
Table Global Peptide Cancer Vaccine Revenue Share by Product (2014-2019)
Figure Global Peptide Cancer Vaccine Revenue Market Share by Product (2014-2019)
Figure Global Peptide Cancer Vaccine Revenue Market Share by Product in 2018
Table Peptide Cancer Vaccine Price by Product 2014-2019 (USD/Dose)
Table Global Peptide Cancer Vaccine Sales by End User (2014-2019) (K Doses)
Table Global Peptide Cancer Vaccine Sales Share by End User (2014-2019)
Figure Global Sales Peptide Cancer Vaccine Market Share by End User (2014-2019)
Figure Global Sales Peptide Cancer Vaccine Market Share by End User in 2018
Figure North America Peptide Cancer Vaccine Sales Growth Rate 2014-2019 (K Doses)
Figure North America Peptide Cancer Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table North America Peptide Cancer Vaccine Sales by Countries (2014-2019) (K Doses)
Table North America Peptide Cancer Vaccine Sales Market Share by Countries (2014-2019)
Figure 2018 North America Peptide Cancer Vaccine Sales Market Share by Countries
Table North America Peptide Cancer Vaccine Revenue by Countries (2014-2019) (Million US$)
Table North America Peptide Cancer Vaccine Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Peptide Cancer Vaccine Revenue Market Share by Countries
Figure United States Peptide Cancer Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure United States Peptide Cancer Vaccine Revenue Growth Rate (2014-2019) (K Doses)
Figure Canada Peptide Cancer Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Canada Peptide Cancer Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Peptide Cancer Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Mexico Peptide Cancer Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Table North America Peptide Cancer Vaccine Sales by Product (2014-2019) (K Doses)
Table North America Peptide Cancer Vaccine Sales Market Share by Product (2014-2019)
Figure 2018 North America Peptide Cancer Vaccine Market Share by Product
Table North America Peptide Cancer Vaccine Sales by End User (2014-2019) (K Doses)
Table North America Peptide Cancer Vaccine Sales Market Share by End User (2014-2019)
Figure 2018 North America Peptide Cancer Vaccine Market Share by End User
Figure Europe Peptide Cancer Vaccine Sales Growth Rate 2014-2019 (K Doses)
Figure Europe Peptide Cancer Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Peptide Cancer Vaccine Sales by Countries (2014-2019) (K Doses)
Table Europe Peptide Cancer Vaccine Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Peptide Cancer Vaccine Sales Market Share by Countries
Table Europe Peptide Cancer Vaccine Revenue by Countries (2014-2019) (Million US$)
Table Europe Peptide Cancer Vaccine Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Peptide Cancer Vaccine Revenue Market Share by Countries
Figure Germany Peptide Cancer Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Germany Peptide Cancer Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure France Peptide Cancer Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure France Peptide Cancer Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Peptide Cancer Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure UK Peptide Cancer Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Peptide Cancer Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Italy Peptide Cancer Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Peptide Cancer Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Russia Peptide Cancer Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Peptide Cancer Vaccine Sales by Product (2014-2019) (K Doses)
Table Europe Peptide Cancer Vaccine Sales Market Share by Product (2014-2019)
Figure 2018 Europe Peptide Cancer Vaccine Market Share by Product
Table Europe Peptide Cancer Vaccine Sales by End User (2014-2019) (K Doses)
Table Europe Peptide Cancer Vaccine Sales Market Share by End User (2014-2019)
Figure 2018 Europe Peptide Cancer Vaccine Market Share by End User
Figure Asia Pacific Peptide Cancer Vaccine Sales Growth Rate 2014-2019 (K Doses)
Figure Asia Pacific Peptide Cancer Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Peptide Cancer Vaccine Sales by Countries (2014-2019) (K Doses)
Table Asia Pacific Peptide Cancer Vaccine Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Peptide Cancer Vaccine Sales Market Share by Countries
Table Asia Pacific Peptide Cancer Vaccine Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Peptide Cancer Vaccine Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Peptide Cancer Vaccine Revenue Market Share by Countries
Figure China Peptide Cancer Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure China Peptide Cancer Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Peptide Cancer Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Japan Peptide Cancer Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Peptide Cancer Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Korea Peptide Cancer Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure India Peptide Cancer Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure India Peptide Cancer Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Peptide Cancer Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Australia Peptide Cancer Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Peptide Cancer Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Indonesia Peptide Cancer Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Peptide Cancer Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Malaysia Peptide Cancer Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Peptide Cancer Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Philippines Peptide Cancer Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Peptide Cancer Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Thailand Peptide Cancer Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Peptide Cancer Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Vietnam Peptide Cancer Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Peptide Cancer Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Singapore Peptide Cancer Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Peptide Cancer Vaccine Sales by Product (2014-2019) (K Doses)
Table Asia Pacific Peptide Cancer Vaccine Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Peptide Cancer Vaccine Market Share by Product
Table Asia Pacific Peptide Cancer Vaccine Sales by End User (2014-2019) (K Doses)
Table Asia Pacific Peptide Cancer Vaccine Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Peptide Cancer Vaccine Market Share by End User
Figure Central & South America Peptide Cancer Vaccine Sales Growth Rate 2014-2019 (K Doses)
Figure Central & South America Peptide Cancer Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Peptide Cancer Vaccine Sales by Countries (2014-2019) (K Doses)
Table Central & South America Peptide Cancer Vaccine Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Peptide Cancer Vaccine Sales Market Share by Countries
Table Central & South America Peptide Cancer Vaccine Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Peptide Cancer Vaccine Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Peptide Cancer Vaccine Revenue Market Share by Countries
Figure Brazil Peptide Cancer Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Brazil Peptide Cancer Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Peptide Cancer Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Argentina Peptide Cancer Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Peptide Cancer Vaccine Sales by Product (2014-2019) (K Doses)
Table Central & South America Peptide Cancer Vaccine Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Peptide Cancer Vaccine Market Share by Product
Table Central & South America Peptide Cancer Vaccine Sales by End User (2014-2019) (K Doses)
Table Central & South America Peptide Cancer Vaccine Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Peptide Cancer Vaccine Market Share by End User
Figure Middle East and Africa Peptide Cancer Vaccine Sales Growth Rate 2014-2019 (K Doses)
Figure Middle East and Africa Peptide Cancer Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Peptide Cancer Vaccine Sales by Countries (2014-2019) (K Doses)
Table Middle East and Africa Peptide Cancer Vaccine Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Peptide Cancer Vaccine Sales Market Share by Countries
Table Middle East and Africa Peptide Cancer Vaccine Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Peptide Cancer Vaccine Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Peptide Cancer Vaccine Revenue Market Share by Countries
Figure GCC Countries Peptide Cancer Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure GCC Countries Peptide Cancer Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Peptide Cancer Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Turkey Peptide Cancer Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Peptide Cancer Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Egypt Peptide Cancer Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Peptide Cancer Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure South Africa Peptide Cancer Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Peptide Cancer Vaccine Sales by Product (2014-2019) (K Doses)
Table Middle East and Africa Peptide Cancer Vaccine Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Peptide Cancer Vaccine Market Share by Product
Table Middle East and Africa Peptide Cancer Vaccine Sales by End User (2014-2019) (K Doses)
Table Middle East and Africa Peptide Cancer Vaccine Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Peptide Cancer Vaccine Market Share by End User
Table TapImmune Company Details
Table TapImmune Peptide Cancer Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table TapImmune Recent Development
Table BrightPath Biotherapeutics Company Details
Table BrightPath Biotherapeutics Peptide Cancer Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table BrightPath Biotherapeutics Recent Development
Table Ultimovacs Company Details
Table Ultimovacs Peptide Cancer Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table Ultimovacs Recent Development
Table Sellas Company Details
Table Sellas Peptide Cancer Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table Sellas Recent Development
Table Boston Biomedical Company Details
Table Boston Biomedical Peptide Cancer Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table Boston Biomedical Recent Development
Table Imugene Company Details
Table Imugene Peptide Cancer Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table Imugene Recent Development
Table VAXON Biotech Company Details
Table VAXON Biotech Peptide Cancer Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table VAXON Biotech Recent Development
Table Generex Biotechnology Company Details
Table Generex Biotechnology Peptide Cancer Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table Generex Biotechnology Recent Development
Table ISA Pharmaceuticals Company Details
Table ISA Pharmaceuticals Peptide Cancer Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table ISA Pharmaceuticals Recent Development
Table OncoTherapy Science Company Details
Table OncoTherapy Science Peptide Cancer Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table OncoTherapy Science Recent Development
Table Immatics Company Details
Table Global Peptide Cancer Vaccine Sales Forecast by Regions 2019-2025 (K Doses)
Table Global Peptide Cancer Vaccine Sales Market Share Forecast by Regions 2019-2025
Table Global Peptide Cancer Vaccine Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Peptide Cancer Vaccine Revenue Market Share Forecast by Regions 2019-2025
Table Global Peptide Cancer Vaccine Sales Forecast by Product 2019-2025 (K Doses)
Table Global Peptide Cancer Vaccine Sales Market Share Forecast by Product 2019-2025
Table Global Peptide Cancer Vaccine Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Peptide Cancer Vaccine Revenue Market Share Forecast by Product 2019-2025
Table Global Peptide Cancer Vaccine Sales Forecast by End User 2019-2025 (K Doses)
Table Global Peptide Cancer Vaccine Sales Market Share Forecast by End User 2019-2025
Figure North America Peptide Cancer Vaccine Sales Growth Rate Forecast (2019-2025) (K Doses)
Figure North America Peptide Cancer Vaccine Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Peptide Cancer Vaccine Sales Growth Rate Forecast (2019-2025) (K Doses)
Figure Europe Peptide Cancer Vaccine Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Peptide Cancer Vaccine Sales Growth Rate Forecast (2019-2025) (K Doses)
Figure Asia Pacific Peptide Cancer Vaccine Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Peptide Cancer Vaccine Sales Growth Rate Forecast (2019-2025) (K Doses)
Figure Central & South America Peptide Cancer Vaccine Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Peptide Cancer Vaccine Sales Growth Rate Forecast (2019-2025) (K Doses)
Figure Middle East and Africa Peptide Cancer Vaccine Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Peptide Cancer Vaccine Value Chain
Table Peptide Cancer Vaccine Customers List
Table Peptide Cancer Vaccine Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Peptide Cancer Vaccine Market Growth 2020-2025
    Published: 12-Feb-2020        Price: US 3660 Onwards        Pages: 165
    According to this study, over the next five years the Peptide Cancer Vaccine market will register a 23.0% CAGR in terms of revenue, the global market size will reach $ 937.1 million by 2025, from $ 409 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Peptide Cancer Vaccine business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Peptide Cancer Vaccine......
  • Global Cancer Vaccine Market Research Report 2020
    Published: 12-Feb-2020        Price: US 2900 Onwards        Pages: 96
    This report focuses on Cancer Vaccine volume and value at global level, regional level and company level. From a global perspective, this report represents overall Cancer Vaccine market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan. At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this r......
  • Peptide Cancer Vaccine Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
    Published: 09-Feb-2020        Price: US 3000 Onwards        Pages: 138
    Peptide Cancer Vaccine Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Peptide Cancer Vaccine industry with a focus on the Chinese market. The report provides key statistics on the market status of the Peptide Cancer Vaccine manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Overall, the report provides an in-depth insight of 2014-2024 global and Chine......
  • Cervical Cancer Vaccine Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
    Published: 09-Feb-2020        Price: US 3000 Onwards        Pages: 141
    Cervical Cancer Vaccine Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Cervical Cancer Vaccine industry with a focus on the Chinese market. The report provides key statistics on the market status of the Cervical Cancer Vaccine manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Overall, the report provides an in-depth insight of 2014-2024 global and Ch......
  • Global Dendritic Cell Cancer Vaccine Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
    Published: 08-Feb-2020        Price: US 3480 Onwards        Pages: 137
    Market Overview The global Dendritic Cell Cancer Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Dendritic Cell Cancer Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Lan......
  • BCG Vaccine Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
    Published: 08-Feb-2020        Price: US 3000 Onwards        Pages: 144
    BCG Vaccine Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global BCG Vaccine industry with a focus on the Chinese market. The report provides key statistics on the market status of the BCG Vaccine manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Overall, the report provides an in-depth insight of 2014-2024 global and Chinese BCG Vaccine market covering al......
  • Cancer Vaccine Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
    Published: 06-Feb-2020        Price: US 3000 Onwards        Pages: 147
    Cancer Vaccine Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Cancer Vaccine industry with a focus on the Chinese market. The report provides key statistics on the market status of the Cancer Vaccine manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.Overall, the report provides an in-depth insight of 2014-2024 global and Chinese Cancer Vaccine market ......
  • Global Dendritic Cell Cancer Vaccine Market Research Report 2020
    Published: 06-Feb-2020        Price: US 2900 Onwards        Pages: 116
    Dendritic cells (DCs) refer to rare kind of leukocytes. They have prompted their recent application to therapeutic cancer vaccinations as they are uniquely effective in their ability to present antigens to T cells. The global Dendritic Cell Cancer Vaccine market is valued at xx million US$ in 2020 is expected to reach xx million US$ by the end of 2026, growing at a CAGR of xx% during 2021-2026. This report focuses on Dendritic Cell Cancer Vaccine volume and value at the glo......
  • Dendritic Cell Cancer Vaccine Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
    Published: 06-Feb-2020        Price: US 3000 Onwards        Pages: 142
    Dendritic Cell Cancer Vaccine Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Dendritic Cell Cancer Vaccine industry with a focus on the Chinese market. The report provides key statistics on the market status of the Dendritic Cell Cancer Vaccine manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.Overall, the report provides an in-depth insight of 2014-2......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs